|
|
Volumn 119, Issue , 2001, Pages 1S-2S
|
|
The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis
a a a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
CLOPIDOGREL;
FIBRINOGEN RECEPTOR ANTAGONIST;
FIBRINOLYTIC AGENT;
TICLOPIDINE;
WARFARIN;
ANTICOAGULANT THERAPY;
ATHEROSCLEROSIS;
CEREBROVASCULAR DISEASE;
CONFERENCE PAPER;
COST BENEFIT ANALYSIS;
DOSE RESPONSE;
DRUG EFFICACY;
EVIDENCE BASED MEDICINE;
HEART ATRIUM FIBRILLATION;
HUMAN;
PRIORITY JOURNAL;
RISK FACTOR;
THROMBOEMBOLISM;
TREATMENT INDICATION;
FIBRINOLYTIC AGENTS;
HUMANS;
SOCIETIES, MEDICAL;
THROMBOSIS;
|
|
EID: 0035129365
PISSN: 00123692
EISSN: None
Source Type: Journal
DOI: 10.1378/chest.119.1_suppl.1s Document Type: Article |
|
Times cited : (158)
|
|
References (2)
|
